CIM Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.37M | Buy |
24,092
+12,023
| +100% | +$1.18M | 0.45% | 41 |
|
|
2025
Q1 | $1.22M | Sell |
12,069
-9
| -0.1% | -$908 | 0.28% | 46 |
|
|
2024
Q4 | $1.08M | Buy |
12,078
+55
| +0.5% | +$4.91K | 0.32% | 53 |
|
|
2024
Q3 | $1.01M | Sell |
12,023
-215
| -2% | -$18K | 0.3% | 59 |
|
|
2024
Q2 | $942K | Sell |
12,238
-71
| -0.6% | -$5.47K | 0.29% | 64 |
|
|
2024
Q1 | $843K | Hold |
12,309
| – | – | 0.25% | 75 |
|
|
2023
Q4 | $712K | Hold |
12,309
| – | – | 0.23% | 90 |
|
|
2023
Q3 | $650K | Sell |
12,309
-298
| -2% | -$15.7K | 0.24% | 91 |
|
|
2023
Q2 | $682K | Buy |
12,607
+31
| +0.2% | +$1.68K | 0.23% | 93 |
|
|
2023
Q1 | $629K | Buy |
12,576
+616
| +5% | +$30.8K | 0.23% | 94 |
|
|
2022
Q4 | $553K | Sell |
11,960
-341
| -3% | -$15.8K | 0.22% | 101 |
|
|
2022
Q3 | $476K | Hold |
12,301
| – | – | 0.21% | 105 |
|
|
2022
Q2 | $458K | Sell |
12,301
-69
| -0.6% | -$2.57K | 0.19% | 109 |
|
|
2022
Q1 | $548K | Sell |
12,370
-14
| -0.1% | -$620 | 0.19% | 111 |
|
|
2021
Q4 | $526K | Sell |
12,384
-239
| -2% | -$10.2K | 0.16% | 138 |
|
|
2021
Q3 | $548K | Sell |
12,623
-76
| -0.6% | -$3.3K | 0.17% | 125 |
|
|
2021
Q2 | $543K | Sell |
12,699
-70
| -0.5% | -$2.99K | 0.17% | 129 |
|
|
2021
Q1 | $494K | Sell |
12,769
-496
| -4% | -$19.2K | 0.16% | 139 |
|
|
2020
Q4 | $477K | Sell |
13,265
-219
| -2% | -$7.88K | 0.15% | 132 |
|
|
2020
Q3 | $515K | Sell |
13,484
-147
| -1% | -$5.61K | 0.2% | 106 |
|
|
2020
Q2 | $479K | Buy |
+13,631
| New | +$479K | 0.19% | 107 |
|